Adaptimmune Therapeutics Plc ADR (ADAPY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,412 | 68,379 | 84,043 | 158,779 | 229,584 |
| Marketable Securities | 39,130 | 136,755 | 124,218 | 22,694 | 55,422 |
| Receivables | N/A | 192 | 206 | 1,480 | 10,675 |
| Other current assets | 30,947 | 25,769 | 21,716 | 15,798 | 102 |
| TOTAL | $120,489 | $231,095 | $230,183 | $198,751 | $295,784 |
| Non-Current Assets | |||||
| PPE Net | 31,068 | 36,118 | 40,679 | 27,899 | 5,404 |
| Intangibles | 2,198 | 1,473 | 1,337 | 1,268 | 178 |
| Other Non-Current Assets | 27,788 | 8,050 | 8,948 | 6,597 | 0 |
| TOTAL | $61,054 | $45,641 | $50,964 | $35,764 | $5,583 |
| Total Assets | $181,543 | $276,736 | $281,147 | $234,515 | $301,366 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,357 | 4,083 | 8,378 | 11,350 | 26,781 |
| Accrued Expenses | 23,363 | 20,354 | 27,201 | 17,528 | N/A |
| TOTAL | $34,341 | $24,437 | $74,314 | $40,270 | $26,821 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,128 | N/A | 38,735 | 11,392 | N/A |
| Other Non-Current Liabilities | 23,564 | 5,414 | 3,849 | 3,141 | 14,343 |
| TOTAL | $23,564 | $5,414 | $3,849 | $28,103 | $14,343 |
| Total Liabilities | $57,905 | $29,851 | $78,163 | $68,373 | $41,163 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 130,075 | N/A | N/A | 70,796 | N/A |
| Common Shares | 943 | 939 | 854 | 683 | 670 |
| Retained earnings | -455,664 | -318,499 | -231,630 | -161,492 | -47,266 |
| Other shareholders' equity | -7,264 | -9,763 | -21,641 | -14,249 | 126,980 |
| TOTAL | $123,638 | $246,885 | $202,984 | $166,142 | $260,203 |
| Total Liabilities And Equity | $181,543 | $276,736 | $281,147 | $234,515 | $301,366 |